Replies to post #10002 on PE pennies

[e-ore]

Merger there. Looks like a lot of shares will be issued

Signal Genetics, Inc. and Miragen Therapeutics, Inc. (“miRagen”), a privately-held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of miRagen are currently estimated to become holders of approximately 96% of Signal’s outstanding common stock on a fully-diluted basis.